Two New Team Members

Prof. Jing-Dong J. Han Ph.D. (H-index 62)
Tenured Boya Professor at Peking University, Director of the Decoding Aging Research Center at Peking University Chengdu Academy for Advanced Interdisciplinary Biotechnologies. Her research focuses on the structure and dynamic inference of molecular networks, using a combination of large-scale experiments and computational analysis to probe the networks and to integrate functional interaction data in order to explore the design principles of the networks aging and development. Her group innovatively developed the first 3D facial aging clocks and thermal facial aging clocks, and recently a machine learning based Senecent Cell Identification program SenCID. She was awarded the Chinese Academy Sciences Hundred Talent Plan and NSFC Outstanding Young Scientist Award, the National Talent Program Outstanding Contribution Award and Shanghai Science Leadership Award, and was selected as a Max Planck Follow and a MaxNetAging Fellow.

Markus G. Manz, M.D. (H-Index 72)
M.G. Manz is a German/Swiss physician scientist. He studied medicine, obtained his doctoral degree and completed his medical training in internal medicine, hematology and oncology at the University of Tubingen in Germany. Following postdoctoral research at Stanford University, USA, he established his research group at the Institute for Research in Biomedicine in Bellinzona, Switzerland. In parallel, he worked as an attending physician at the Oncology Institute of Southern Switzerland.
Since 2009, M.G. Manz is Professor of Hematology at the University of Zurich and director of the division of hematology at the University Hospital Zurich. In 2017 he became director of the department for Medical Oncology and Hematology at the University Hospital of Zurich. He also leads the center for Hemato-Oncology and the Comprehensive Cancer Center Zurich. He is past president of the Swiss Society of Hematology.
His clinical and experimental laboratory research focuses on healthy hematopoiesis in the context of aging and inflammation, as well as on hematopoietic stem cell malignancies and the improvement of respective treatment options, with a special focus on novel immunotherapeutic approaches.
M.G. Manz received several prestigious awards. He is elected member of the Swiss Academy of Medical Sciences and advises on national and international organizations for the promotion of cancer research and treatment.